Showing results (871-880 of 3,351) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|June 26, 2004
Growth hormone therapy and quality of life in adults and childrenDeborah J Radcliffe, Joseph S Pliskin, J B Silvers, et al.Pharmacoeconomics|August 27, 2004
Acute rhinosinusitis : a pharmacoeconomic review of antibacterial useJean-Blaise Wasserfallen, Françoise Livio, Giorgio ZanettiPharmacoeconomics|July 15, 2004
The measurement of contingent valuation for health economicsAhmed M BayoumiPharmacoeconomics|July 15, 2004
Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspectiveMauro Percudani, Corrado Barbui, Michele TansellaPharmacoeconomics|May 13, 2004
Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsisJames E Frampton, Rachel H FosterPharmacoeconomics|May 26, 2004
Epidemiology and burden of illness of rheumatoid arthritisTore K KvienPharmacoeconomics|April 6, 2004
How often do sensitivity analyses for economic parameters change cost-utility analysis conclusions?Bruce R Schackman, Heather Taffet Gold, Patricia W Stone, et al.Pharmacoeconomics|May 7, 2005
The value of clopidogrel versus aspirin in reducing atherothrombotic events: the CAPRIE studyIsabelle Durand-Zaleski, Michel BertrandPharmacoeconomics|April 20, 2005
The economic impact of neuropsychiatric symptoms in Alzheimer's disease: can drugs ease the burden?Daniel L Murman, Christopher C ColendaPharmacoeconomics|September 4, 2004
Cost effectiveness of therapies for atrial fibrillation. A reviewM P Teng, L E Catherwood, D P MelbyPageof 336